Provider communication and HPV vaccine uptake: A meta-analysis and systematic review
Provider communication can be critically important to families as they consider HPV vaccination. We sought to characterize the association of provider communication and HPV vaccine uptake, and when communication better motivates vaccination. We searched four databases for studies published between 2...
Uloženo v:
| Vydáno v: | Preventive medicine Ročník 148; s. 106554 |
|---|---|
| Hlavní autoři: | , , , |
| Médium: | Journal Article |
| Jazyk: | angličtina |
| Vydáno: |
United States
Elsevier Inc
01.07.2021
|
| Témata: | |
| ISSN: | 0091-7435, 1096-0260, 1096-0260 |
| On-line přístup: | Získat plný text |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!
|
| Abstract | Provider communication can be critically important to families as they consider HPV vaccination. We sought to characterize the association of provider communication and HPV vaccine uptake, and when communication better motivates vaccination. We searched four databases for studies published between 2006 and 2019. Eligible studies examined health care provider communication (defined as recommendation or discussion) and HPV vaccine uptake (defined as initiation, completion, or follow-through) in the US. Two coders independently identified eligible studies and coded effect sizes and study characteristics. We pooled effect sizes using random-effects meta-analysis. We identified 59 eligible studies of 265,083 patients. Receiving a provider recommendation was associated with higher HPV vaccine initiation (pooled OR = 10.1, 95% CI: 7.6–13.4). HPV vaccine initiation was 24% for patients without and 60% for patients with a provider recommendation. The pooled effect size for provider recommendation and initiation was smaller for probability samples, clinical records, and NIS-Teen (all p < 0.002). Recommendations were equally effective for males and females, for different patient ages, and over time. Provider recommendation was also associated with higher HPV vaccine series completion and follow-through. Provider discussion was similarly associated with higher HPV vaccine initiation (OR = 12.4, 95% CI: 6.3–24.3). In summary, provider communication was robustly associated with HPV vaccination initiation, completion, and follow-through. These findings suggest that US public health efforts to increase HPV vaccine coverage should continue to emphasize provider communication.
•Provider recommendation has a robust association with HPV vaccination initiation, completion, and follow-through.•A greater percentage of patients initiated HPV vaccination when receiving a provider recommendation.•HPV vaccination uptake with provider recommendation occurs in females and males across ages and over time.•Provider discussion has a similarly robust association with HPV vaccination initiation compared to provider recommendation.•Provider communication should be an essential part of efforts to increase HPV vaccination coverage in the United States. |
|---|---|
| AbstractList | Provider communication can be critically important to families as they consider HPV vaccination. We sought to characterize the association of provider communication and HPV vaccine uptake, and when communication better motivates vaccination. We searched four databases for studies published between 2006 and 2019. Eligible studies examined health care provider communication (defined as recommendation or discussion) and HPV vaccine uptake (defined as initiation, completion, or follow-through) in the US. Two coders independently identified eligible studies and coded effect sizes and study characteristics. We pooled effect sizes using random-effects meta-analysis. We identified 59 eligible studies of 265,083 patients. Receiving a provider recommendation was associated with higher HPV vaccine initiation (pooled OR = 10.1, 95% CI: 7.6-13.4). HPV vaccine initiation was 24% for patients without and 60% for patients with a provider recommendation. The pooled effect size for provider recommendation and initiation was smaller for probability samples, clinical records, and NIS-Teen (all p < 0.002). Recommendations were equally effective for males and females, for different patient ages, and over time. Provider recommendation was also associated with higher HPV vaccine series completion and follow-through. Provider discussion was similarly associated with higher HPV vaccine initiation (OR = 12.4, 95% CI: 6.3-24.3). In summary, provider communication was robustly associated with HPV vaccination initiation, completion, and follow-through. These findings suggest that US public health efforts to increase HPV vaccine coverage should continue to emphasize provider communication. Provider communication can be critically important to families as they consider HPV vaccination. We sought to characterize the association of provider communication and HPV vaccine uptake, and when communication better motivates vaccination. We searched four databases for studies published between 2006 and 2019. Eligible studies examined health care provider communication (defined as recommendation or discussion) and HPV vaccine uptake (defined as initiation, completion, or follow-through) in the US. Two coders independently identified eligible studies and coded effect sizes and study characteristics. We pooled effect sizes using random-effects meta-analysis. We identified 59 eligible studies of 265,083 patients. Receiving a provider recommendation was associated with higher HPV vaccine initiation (pooled OR = 10.1, 95% CI: 7.6–13.4). HPV vaccine initiation was 24% for patients without and 60% for patients with a provider recommendation. The pooled effect size for provider recommendation and initiation was smaller for probability samples, clinical records, and NIS-Teen (all p < 0.002). Recommendations were equally effective for males and females, for different patient ages, and over time. Provider recommendation was also associated with higher HPV vaccine series completion and follow-through. Provider discussion was similarly associated with higher HPV vaccine initiation (OR = 12.4, 95% CI: 6.3–24.3). In summary, provider communication was robustly associated with HPV vaccination initiation, completion, and follow-through. These findings suggest that US public health efforts to increase HPV vaccine coverage should continue to emphasize provider communication. •Provider recommendation has a robust association with HPV vaccination initiation, completion, and follow-through.•A greater percentage of patients initiated HPV vaccination when receiving a provider recommendation.•HPV vaccination uptake with provider recommendation occurs in females and males across ages and over time.•Provider discussion has a similarly robust association with HPV vaccination initiation compared to provider recommendation.•Provider communication should be an essential part of efforts to increase HPV vaccination coverage in the United States. Provider communication can be critically important to families as they consider HPV vaccination. We sought to characterize the association of provider communication and HPV vaccine uptake, and when communication better motivates vaccination. We searched four databases for studies published between 2006 and 2019. Eligible studies examined health care provider communication (defined as recommendation or discussion) and HPV vaccine uptake (defined as initiation, completion, or follow-through) in the US. Two coders independently identified eligible studies and coded effect sizes and study characteristics. We pooled effect sizes using random-effects meta-analysis. We identified 59 eligible studies of 265,083 patients. Receiving a provider recommendation was associated with higher HPV vaccine initiation (pooled OR = 10.1, 95% CI: 7.6-13.4). HPV vaccine initiation was 24% for patients without and 60% for patients with a provider recommendation. The pooled effect size for provider recommendation and initiation was smaller for probability samples, clinical records, and NIS-Teen (all p < 0.002). Recommendations were equally effective for males and females, for different patient ages, and over time. Provider recommendation was also associated with higher HPV vaccine series completion and follow-through. Provider discussion was similarly associated with higher HPV vaccine initiation (OR = 12.4, 95% CI: 6.3-24.3). In summary, provider communication was robustly associated with HPV vaccination initiation, completion, and follow-through. These findings suggest that US public health efforts to increase HPV vaccine coverage should continue to emphasize provider communication.Provider communication can be critically important to families as they consider HPV vaccination. We sought to characterize the association of provider communication and HPV vaccine uptake, and when communication better motivates vaccination. We searched four databases for studies published between 2006 and 2019. Eligible studies examined health care provider communication (defined as recommendation or discussion) and HPV vaccine uptake (defined as initiation, completion, or follow-through) in the US. Two coders independently identified eligible studies and coded effect sizes and study characteristics. We pooled effect sizes using random-effects meta-analysis. We identified 59 eligible studies of 265,083 patients. Receiving a provider recommendation was associated with higher HPV vaccine initiation (pooled OR = 10.1, 95% CI: 7.6-13.4). HPV vaccine initiation was 24% for patients without and 60% for patients with a provider recommendation. The pooled effect size for provider recommendation and initiation was smaller for probability samples, clinical records, and NIS-Teen (all p < 0.002). Recommendations were equally effective for males and females, for different patient ages, and over time. Provider recommendation was also associated with higher HPV vaccine series completion and follow-through. Provider discussion was similarly associated with higher HPV vaccine initiation (OR = 12.4, 95% CI: 6.3-24.3). In summary, provider communication was robustly associated with HPV vaccination initiation, completion, and follow-through. These findings suggest that US public health efforts to increase HPV vaccine coverage should continue to emphasize provider communication. AbstractProvider communication can be critically important to families as they consider HPV vaccination. We sought to characterize the association of provider communication and HPV vaccine uptake, including when communication better motivates vaccination. We searched four databases for studies published between 2006 and 2019. Eligible studies examined health care provider communication (defined as recommendation or discussion) and HPV vaccine uptake (defined as initiation, completion, or follow-through) in the US. Two coders independently identified eligible studies and coded effect sizes and study characteristics. We pooled effect sizes using random-effects meta-analysis. We identified 59 eligible studies of 265,083 patients. Receiving a provider recommendation was associated with higher HPV vaccine initiation (pooled OR = 10.1, 95% CI: 7.6–13.4). HPV vaccine initiation was 24% for patients without and 60% for patients with a provider recommendation. The pooled effect size for provider recommendation and initiation was smaller for probability samples, clinical records, and NIS-Teen (all p < 0.002). Recommendations were equally effective for males and females, for different patient ages, and over time. Provider recommendation was also associated with higher HPV vaccine series completion and follow-through. Provider discussion was similarly associated with higher HPV vaccine initiation (OR = 12.4, 95% CI: 6.3–24.3). In summary, provider communication was robustly associated with HPV vaccination initiation, completion, and follow-through. These findings suggest that US public health efforts to increase HPV vaccine coverage should continue to emphasize provider communication. |
| ArticleNumber | 106554 |
| Author | Biddell, Caitlin B. Brewer, Noel T. Oh, N. Loren Rhodes, Blythe E. |
| Author_xml | – sequence: 1 givenname: N. Loren surname: Oh fullname: Oh, N. Loren organization: University of North Carolina School of Medicine, United States of America – sequence: 2 givenname: Caitlin B. surname: Biddell fullname: Biddell, Caitlin B. organization: Department of Health Policy and Management, Gillings School of Global Public Health, University of North Carolina, United States of America – sequence: 3 givenname: Blythe E. surname: Rhodes fullname: Rhodes, Blythe E. organization: Department of Health Behavior, Gillings School of Global Public Health, University of North Carolina, United States of America – sequence: 4 givenname: Noel T. surname: Brewer fullname: Brewer, Noel T. email: ntb@unc.edu organization: Department of Health Behavior, Gillings School of Global Public Health, University of North Carolina, United States of America |
| BackLink | https://www.ncbi.nlm.nih.gov/pubmed/33857561$$D View this record in MEDLINE/PubMed |
| BookMark | eNqFktGK1DAUhoOsuLOrTyBIL73pbE6Tpq2isCzqCgsuOHgb0vQUMtsmY5KO9O1NZ9a9WJC5SSD83x_4zrkgZ9ZZJOQt0DVQEFfb9bwbsVsXtID0IsqSvyAroI3IaSHoGVlR2kBecVaek4sQtpQCCMpfkXPG6rIqBazI5t67venQZ9qN42SNVtE4mynbZbf3v7K90tpYzKZdVA_4IbvORowqV1YNczDhkAtziDgmTmce9wb_vCYvezUEfPN4X5LN1y-bm9v87se37zfXd7nmQsTlLCvgrBU9bau2EUyLooSaCaxZxXnbIe8VIgdddaynitcN1zVvOVBaN-ySvD_W7rz7PWGIcjRB4zAoi24KMnXxsmEgIEXfPUanNjmTO29G5Wf5T0QKsGNAexeCx_4pAlQuuuVWHnTLRbc86k5U84zSJh4ERq_McIL9dGQxGUrWvAzaoNXYGY86ys6ZE_znZ7wezDK_4QFnDFs3-TSkIEGGQlL5c1mGZReKJA_YQd_H_xec_P4vCljDjQ |
| CitedBy_id | crossref_primary_10_1007_s13187_022_02188_2 crossref_primary_10_1016_j_vaccine_2025_127302 crossref_primary_10_3390_vaccines12121374 crossref_primary_10_1007_s13187_022_02248_7 crossref_primary_10_1016_j_vaccine_2024_05_008 crossref_primary_10_1016_j_jadohealth_2021_08_021 crossref_primary_10_1080_10810730_2024_2386594 crossref_primary_10_1016_j_pmedr_2025_103194 crossref_primary_10_1016_j_vaccine_2023_09_027 crossref_primary_10_1089_whr_2025_0015 crossref_primary_10_1007_s10900_024_01401_1 crossref_primary_10_1016_j_jadohealth_2025_06_015 crossref_primary_10_3390_vaccines13090917 crossref_primary_10_1016_j_jadohealth_2023_02_006 crossref_primary_10_1002_nop2_70110 crossref_primary_10_1093_inthealth_ihac007 crossref_primary_10_3390_vaccines13020130 crossref_primary_10_1111_hex_70422 crossref_primary_10_1007_s13187_025_02659_2 crossref_primary_10_2196_34070 crossref_primary_10_1186_s12913_023_09415_6 crossref_primary_10_1007_s00103_025_04029_1 crossref_primary_10_1177_13591053231189413 crossref_primary_10_1016_j_lana_2025_101243 crossref_primary_10_1080_07448481_2024_2409687 crossref_primary_10_1136_sextrans_2023_055961 crossref_primary_10_1016_j_mcna_2023_06_009 crossref_primary_10_3389_fgwh_2025_1667727 crossref_primary_10_1093_infdis_jiad055 crossref_primary_10_1177_10598405231206109 crossref_primary_10_1080_21645515_2023_2291859 crossref_primary_10_2196_42890 crossref_primary_10_15585_mmwr_mm7050a1 crossref_primary_10_1016_j_acap_2022_01_008 crossref_primary_10_2196_38164 crossref_primary_10_3390_pathogens12030397 crossref_primary_10_1080_21645515_2024_2347018 crossref_primary_10_1136_bmj_p2978 crossref_primary_10_3390_vaccines12101194 crossref_primary_10_1080_10410236_2024_2361584 crossref_primary_10_3390_tropicalmed8050251 crossref_primary_10_1007_s40615_023_01754_8 crossref_primary_10_18043_001c_91426 crossref_primary_10_1080_07853890_2022_2045034 crossref_primary_10_1093_lambio_ovaf088 crossref_primary_10_1016_j_healthpol_2023_104894 crossref_primary_10_1007_s10865_022_00326_1 crossref_primary_10_3390_vaccines11020443 crossref_primary_10_1007_s10552_022_01662_y crossref_primary_10_1007_s10552_025_02040_0 crossref_primary_10_1097_MOP_0000000000001441 crossref_primary_10_1093_heapro_daad153 crossref_primary_10_3390_vaccines10122025 crossref_primary_10_15585_mmwr_mm7239a1 crossref_primary_10_1080_21645515_2023_2178219 crossref_primary_10_3390_vaccines13060599 crossref_primary_10_1007_s10865_022_00296_4 crossref_primary_10_1016_j_jadohealth_2023_06_026 crossref_primary_10_1016_j_vaccine_2022_11_007 crossref_primary_10_1093_ofid_ofad004 crossref_primary_10_3390_vaccines11020279 crossref_primary_10_1080_21645515_2022_2122494 crossref_primary_10_1093_fampra_cmac018 crossref_primary_10_1542_pedsos_2024_000263 crossref_primary_10_1080_21645515_2025_2478705 crossref_primary_10_1002_cncr_34521 crossref_primary_10_1007_s10552_025_02027_x crossref_primary_10_1016_j_jadohealth_2023_01_004 crossref_primary_10_3390_vaccines11061096 crossref_primary_10_1016_j_jogn_2021_10_001 crossref_primary_10_1146_annurev_publhealth_071723_111427 crossref_primary_10_1016_j_ypmed_2023_107472 crossref_primary_10_3390_vaccines11020300 crossref_primary_10_1016_j_amepre_2022_06_016 crossref_primary_10_1002_lary_30130 crossref_primary_10_1007_s13187_024_02462_5 crossref_primary_10_3389_fpubh_2024_1343064 crossref_primary_10_1016_j_pcl_2022_11_009 crossref_primary_10_1371_journal_pone_0312700 crossref_primary_10_1097_PHH_0000000000001838 crossref_primary_10_1007_s13187_021_02123_x crossref_primary_10_1080_15267431_2024_2404865 crossref_primary_10_1080_17441692_2025_2516696 crossref_primary_10_1016_S2352_4642_21_00312_6 crossref_primary_10_1016_j_acap_2024_102609 crossref_primary_10_1016_j_jpedcp_2025_200160 crossref_primary_10_1016_j_pmedr_2025_103160 crossref_primary_10_1016_j_vaccine_2024_02_009 crossref_primary_10_1016_j_ypmed_2022_107341 crossref_primary_10_1136_bmjopen_2023_072619 crossref_primary_10_1016_j_jaip_2021_06_035 crossref_primary_10_3390_vaccines13070716 crossref_primary_10_1002_hpm_3665 crossref_primary_10_1016_j_vaccine_2024_126636 crossref_primary_10_3390_healthcare11121702 crossref_primary_10_1080_19317611_2023_2180127 crossref_primary_10_1007_s10900_023_01248_y crossref_primary_10_1080_07448481_2024_2325935 crossref_primary_10_1186_s12912_023_01379_6 crossref_primary_10_1016_j_ypmed_2025_108308 crossref_primary_10_3389_fdgth_2022_888302 crossref_primary_10_1097_AOG_0000000000005904 crossref_primary_10_1177_00099228251324017 crossref_primary_10_3390_vaccines10091515 crossref_primary_10_1080_21645515_2022_2148825 crossref_primary_10_1186_s12889_022_14852_9 crossref_primary_10_1007_s40615_023_01858_1 crossref_primary_10_1080_21645515_2023_2172276 crossref_primary_10_1093_abm_kaaf069 crossref_primary_10_1016_S2468_2667_25_00148_3 crossref_primary_10_3390_cancers17030344 crossref_primary_10_1016_j_jvacx_2025_100683 crossref_primary_10_1016_j_pedhc_2022_11_002 crossref_primary_10_1186_s12889_024_19792_0 crossref_primary_10_1080_21645515_2022_2132755 crossref_primary_10_1097_OLQ_0000000000001663 crossref_primary_10_1093_eurpub_ckad134 crossref_primary_10_1186_s40814_023_01379_y crossref_primary_10_1016_j_jpeds_2022_04_026 crossref_primary_10_1093_rheumatology_keaf316 crossref_primary_10_1371_journal_pone_0323063 crossref_primary_10_1371_journal_pone_0326694 crossref_primary_10_1093_tbm_ibae054 crossref_primary_10_3322_caac_21753 crossref_primary_10_1016_j_jadohealth_2023_11_016 crossref_primary_10_3390_vaccines13090964 crossref_primary_10_3390_vaccines12121405 crossref_primary_10_1016_j_pedn_2022_08_011 crossref_primary_10_3389_fpubh_2023_1272630 crossref_primary_10_1016_j_amepre_2023_01_014 crossref_primary_10_1016_j_vaccine_2022_06_007 crossref_primary_10_1371_journal_pone_0331592 crossref_primary_10_1016_j_jpeds_2022_04_023 crossref_primary_10_1080_21645515_2024_2307735 crossref_primary_10_1093_fampra_cmac056 |
| Cites_doi | 10.1016/j.vaccine.2013.04.041 10.1016/j.amepre.2012.09.003 10.1016/j.coviro.2019.06.006 10.1016/j.jpag.2012.05.004 10.1016/j.acap.2013.01.002 10.1016/j.pvr.2017.04.002 10.1002/cncr.32379 10.1016/j.jadohealth.2009.03.029 10.1186/s12905-016-0323-5 10.2105/AJPH.2012.301189 10.1097/OLQ.0000000000000626 10.15585/mmwr.mm6833a3 10.1177/0009922815579687 10.1093/jnci/djv086 10.3122/jabfm.2015.03.140082 10.1136/sextrans-2015-052088 10.1016/j.vaccine.2016.01.023 10.1353/hpu.2016.0126 10.1016/j.jadohealth.2018.12.001 10.1016/j.vaccine.2014.11.021 10.1016/j.vaccine.2013.04.068 10.1016/j.vaccine.2016.12.045 10.1016/j.vaccine.2009.12.063 10.1097/OLQ.0000000000000408 10.15585/mmwr.mm6832a3 10.1016/j.jadohealth.2009.04.021 10.1097/OLQ.0b013e3181f12dbf 10.1111/jrh.12079 10.1136/bmjopen-2017-019206 10.1016/j.jadohealth.2014.11.023 10.1016/j.vaccine.2014.07.001 10.1016/j.pmedr.2017.10.005 10.1007/s11764-015-0495-2 10.3102/0013189X16656615 10.1111/josh.12229 10.1177/1529100618760521 10.1016/j.jadohealth.2009.02.006 10.1016/j.vaccine.2011.01.065 10.1097/NNR.0000000000000282 10.1542/peds.2019-1475 10.1542/peds.2012-3122 10.1016/j.jadohealth.2010.04.003 10.1002/ijc.30716 10.1093/her/cyz014 10.4161/hv.25823 10.15585/mmwr.mm6933a1 10.1016/j.acap.2017.08.010 10.1002/ijgo.12186 10.1016/j.pmedr.2015.10.003 10.1016/j.jadohealth.2012.09.009 10.1016/j.jadohealth.2013.06.006 10.1177/1059840515583312 10.1037/a0027012 10.1016/j.socscimed.2009.05.024 10.1016/j.acap.2017.09.014 10.1200/JCO.2017.74.1843 10.1007/s10995-012-0999-6 10.1007/s10900-012-9572-x 10.1016/S2214-109X(16)30143-7 10.1158/1055-9965.EPI-13-0979 10.1093/jncics/pky045 10.1007/s10935-013-0295-2 10.1001/jamapediatrics.2018.0016 10.1016/j.vaccine.2011.02.045 10.1016/j.jadohealth.2014.08.014 10.1080/21645515.2015.1123359 10.1016/j.jadohealth.2017.02.006 10.1007/s00038-018-1176-5 10.1089/jwh.2009.1861 10.1111/josh.12540 10.1177/0009922818805217 10.1002/pbc.25539 10.1016/j.pec.2016.06.027 10.1080/21645515.2018.1480237 10.1016/j.vaccine.2011.01.052 10.1080/21645515.2017.1332551 10.1158/1940-6207.CAPR-13-0127 |
| ContentType | Journal Article |
| Copyright | 2021 Elsevier Inc. Copyright © 2021 Elsevier Inc. All rights reserved. |
| Copyright_xml | – notice: 2021 Elsevier Inc. – notice: Copyright © 2021 Elsevier Inc. All rights reserved. |
| DBID | AAYXX CITATION CGR CUY CVF ECM EIF NPM 7X8 |
| DOI | 10.1016/j.ypmed.2021.106554 |
| DatabaseName | CrossRef Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed MEDLINE - Academic |
| DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) MEDLINE - Academic |
| DatabaseTitleList | MEDLINE MEDLINE - Academic |
| Database_xml | – sequence: 1 dbid: NPM name: PubMed url: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: 7X8 name: MEDLINE - Academic url: https://search.proquest.com/medline sourceTypes: Aggregation Database |
| DeliveryMethod | fulltext_linktorsrc |
| Discipline | Medicine Public Health |
| EISSN | 1096-0260 |
| EndPage | 106554 |
| ExternalDocumentID | 33857561 10_1016_j_ypmed_2021_106554 S0091743521001389 1_s2_0_S0091743521001389 |
| Genre | Meta-Analysis Research Support, Non-U.S. Gov't Systematic Review Journal Article |
| GroupedDBID | --- --K --M -ET .1- .55 .FO .GJ .~1 0R~ 123 1B1 1CY 1P~ 1RT 1~. 1~5 29O 4.4 457 4G. 53G 5RE 5VS 7-5 71M 8P~ 9JM AABNK AAEDT AAEDW AAIKJ AAKOC AALRI AAOAW AAQFI AAQQT AAQXK AATTM AAWTL AAXKI AAXUO AAYWO ABBQC ABDPE ABFNM ABFRF ABJNI ABMAC ABMZM ABXDB ACDAQ ACGFO ACGFS ACIEU ACLOT ACRLP ACRPL ACVFH ADBBV ADCNI ADEZE ADFGL ADMUD ADNMO ADVLN ADXHL AEBSH AEFWE AEIPS AEKER AENEX AEUPX AEVXI AFFNX AFJKZ AFPUW AFRHN AFTJW AFXIZ AGHFR AGQPQ AGUBO AGYEJ AHHHB AI2 AIEXJ AIGII AIIUN AIKHN AITUG AJRQY AJUYK AKBMS AKRWK AKYEP ALMA_UNASSIGNED_HOLDINGS AMRAJ ANKPU ANZVX APXCP ASPBG AVWKF AXJTR AZFZN BKOJK BLXMC BNPGV CAG COF CS3 DM4 DU5 EBS EFBJH EFKBS EFLBG EJD EO8 EO9 EP2 EP3 F5P FDB FEDTE FGOYB FIRID FNPLU FYGXN G-2 G-Q GBLVA HEA HMK HMO HVGLF HZ~ IH2 IHE J1W KOM LG5 LZ2 M29 M41 MO0 N4W N9A O-L O9- OAUVE OD~ OHT OO0 OZT P-8 P-9 P2P PC. Q38 R2- ROL RPZ SAE SCC SDF SDG SDP SES SEW SPCBC SSH SSZ T5K TWZ UNMZH VJK WUQ X7M XPP Z5R ZGI ZMT ZU3 ~G- ~HD ~KM 0SF AACTN AFCTW AFKWA AJOXV AMFUW NCXOZ PKN RIG 9DU AAYXX CITATION AGCQF AGRNS CGR CUY CVF ECM EIF NPM 7X8 |
| ID | FETCH-LOGICAL-c466t-c4657143b6f0b7b963c6251836e83744bde4faee41c7d3f0a4894c84b4100893 |
| ISICitedReferencesCount | 161 |
| ISICitedReferencesURI | http://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=Summon&SrcAuth=ProQuest&DestLinkType=CitingArticles&DestApp=WOS_CPL&KeyUT=000663549000012&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D |
| ISSN | 0091-7435 1096-0260 |
| IngestDate | Sat Sep 27 20:11:55 EDT 2025 Mon Jul 21 05:57:48 EDT 2025 Tue Nov 18 22:51:21 EST 2025 Sat Nov 29 07:24:29 EST 2025 Sun Apr 06 06:54:34 EDT 2025 Tue Feb 25 20:09:53 EST 2025 Tue Oct 14 19:40:38 EDT 2025 |
| IsPeerReviewed | true |
| IsScholarly | true |
| Keywords | Systematic review HPV vaccines Provider communication Meta-analysis |
| Language | English |
| License | Copyright © 2021 Elsevier Inc. All rights reserved. |
| LinkModel | OpenURL |
| MergedId | FETCHMERGED-LOGICAL-c466t-c4657143b6f0b7b963c6251836e83744bde4faee41c7d3f0a4894c84b4100893 |
| Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 ObjectType-Undefined-3 |
| PMID | 33857561 |
| PQID | 2514593161 |
| PQPubID | 23479 |
| PageCount | 1 |
| ParticipantIDs | proquest_miscellaneous_2514593161 pubmed_primary_33857561 crossref_primary_10_1016_j_ypmed_2021_106554 crossref_citationtrail_10_1016_j_ypmed_2021_106554 elsevier_sciencedirect_doi_10_1016_j_ypmed_2021_106554 elsevier_clinicalkeyesjournals_1_s2_0_S0091743521001389 elsevier_clinicalkey_doi_10_1016_j_ypmed_2021_106554 |
| PublicationCentury | 2000 |
| PublicationDate | 2021-07-01 |
| PublicationDateYYYYMMDD | 2021-07-01 |
| PublicationDate_xml | – month: 07 year: 2021 text: 2021-07-01 day: 01 |
| PublicationDecade | 2020 |
| PublicationPlace | United States |
| PublicationPlace_xml | – name: United States |
| PublicationTitle | Preventive medicine |
| PublicationTitleAlternate | Prev Med |
| PublicationYear | 2021 |
| Publisher | Elsevier Inc |
| Publisher_xml | – name: Elsevier Inc |
| References | Sturm, Donahue, Kasting, Kulkarni, Brewer, Zimet (bb0405) 2017; 61 Nickel, Dodd, Turner (bb0315) 2017; 8 Bar-Shain, Stager, Runkle, Leon, Kaelber (bb0005) 2015; 56 The National Immunization Survey-Teen (bb0475) 2021 Rahman, Laz, McGrath, Berenson (bb0330) 2015; 54 Gerend, Shepherd, Lustria, Shepherd (bb0155) 2016; 92 Klosky, Favaro, Peck (bb0245) 2015; 10 Klosky, Hudson, Chen (bb0255) 2017; 35 McRee, Katz, Paskett, Reiter (bb0295) 2014; 32 Savas, Fernández, Jobe, Carmack (bb0385) 2012; 43 Gerend, Zapata, Reyes (bb0150) 2013; 53 (bb0450) 2015 (bb0470) 2019 (bb0460) 2017 Fu, Zimet, Latkin, Joseph (bb0135) 2017; 35 Reiter, Brewer, Gottlieb, McRee, Smith (bb0335) 2009; 69 Cates, Shafer, Carpentier (bb0055) 2010; 47 Guerry, De Rosa, Markowitz (bb0190) 2011; 29 Hansen, Okoloko, Ogunbajo, North, Niccolai (bb0195) 2017; 87 Gottlieb, Brewer, Sternberg (bb0185) 2009; 45 Senkomago, Henley, Thomas, Mix, Markowitz, Saraiya (bb0390) 2019; 68 (bb0420) 2009 Stokley, Jeyarajah, Yankey (bb0400) 2014; 63 Gerend, Weibley, Bland (bb0145) 2009; 45 Klosky, Russell, Simmons (bb0250) 2015; 62 Hoffman, Okcu, Dreyer, Suzawa, Bryant, Middleman (bb0200) 2012; 25 National HPV Roundtable (bb0305) 2021 (bb0440) 2013 Marchand, Glenn, Bastani (bb0285) 2012; 37 Casey, Crosby, Vanderpool, Dignan, Bates (bb0045) 2013; 34 Meites, Szilagyi, Chesson, Unger, Romero, Markowitz (bb0300) 2019; 68 Cheung, Slavin (bb0070) 2016; 45 LaMontagne, Bloem, Brotherton, Gallagher, Badiane, Ndiaye (bb0275) 2017; 138 Gorbach, Cook, Gratzer (bb0180) 2017; 44 (bb0455) 2016 Reiter, Gupta, Brewer (bb0350) 2014; 23 (bb0445) 2014 Dempsey, Pyrznawoski, Lockhart (bb0105) 2018; 172 Suryadevara, Bonville, Kline (bb0410) 2016; 12 Klosky, Russell, Canavera (bb0240) 2013; 6 Newman, Logie, Lacombe-Duncan (bb0310) 2018; 8 Perkins, Zisblatt, Legler, Trucks, Hanchate, Gorin (bb0320) 2015; 33 Curtis, Dorell, Yankey (bb0080) 2014; 63 Gerend, Madkins, Phillips, Mustanski (bb0160) 2016; 43 Kempe, Allison, Daley (bb0225) 2018; 18 Kharbanda, Stockwell, Fox, Andres, Lara, Rickert (bb0235) 2011; 29 Brewer, Gottlieb, Reiter (bb0030) 2011; 38 Fenton, Eun, Clark, Perkins (bb0120) 2018; 14 Immunization and Infectious Diseases Objectives (bb0220) 2020 de Martel, Plummer, Vignat, Franceschi (bb0090) 2017; 141 Rosenthal, Weiss, Zimet, Ma, Good, Vichnin (bb0365) 2011; 29 Saraiya, Unger, Thompson (bb0380) 2015; 107 Donahue, Hendrix, Sturm, Zimet (bb0110) 2015; 2 Rosen, Goodson, Thompson, Wilson (bb0355) 2015; 85 Williams, Lu, Saraiya (bb0485) 2013; 31 Gold, Naleway, Riedlinger (bb0175) 2013; 52 Szilagyi, Albertin, Humiston (bb0415) 2013; 13 Brewer, Chapman, Rothman, Leask, Kempe (bb0035) 2017; 18 (bb0215) 2021 (bb0205) 2021 Caskey, Lindau, Alexander (bb0050) 2009; 45 Colón-López, Toro-Mejías, Conde-Toro (bb0075) 2016; 27 Bhatta, Phillips (bb0025) 2015; 31 Rosen, Ashwood, Richardson (bb0360) 2016; 32 Plummer, de Martel, Vignat, Ferlay, Bray, Franceschi (bb0325) 2016; 4 Rossi (bb0370) 1987; Vol 4 Bednarczyk, Birkhead, Morse, Doleyres, McNutt (bb0010) 2011; 29 Reiter, McRee, Pepper, Gilkey, Galbraith, Brewer (bb0345) 2013; 103 Ruffin, Plegue, Rockwell, Young, Patel, Yeazel (bb0375) 2015; 28 Reiter, Katz, Paskett (bb0340) 2013; 31 Markowitz, Gee, Chesson, Stokley (bb0290) 2018; 18 Kempe, O’Leary, Markowitz (bb0230) 2019; 144 Gargano, Herbert, Painter (bb0140) 2013; 9 Macdonald (bb0280) 2016; 3 Elam-Evans, Yankey, Singleton (bb0115) 2020; 69 (bb0465) 2018 (bb0425) 2010 (bb0435) 2012 Cherven, Castellino, Chen (bb0065) 2019; 125 Vu, Bednarczyk, Escoffery, Getachew, Berg (bb0480) 2019; 34 Wilson, Hashibe, Bodson (bb0490) 2016; 16 Kramer, Dunlop (bb0260) 2012; 16 Gerend, Stephens, Kazmer, Slate, Reyes (bb0165) 2019; 64 Buechel, Connelly (bb0040) 2018; 67 de Sanjose, Brotons, LaMontagne, Bruni (bb0100) 2019; 39 Berenson, Brown, Fuchs, Hirth, Chang (bb0020) 2017; 13 (bb0210) 2020 Daley, Vamos, Buhi (bb0085) 2010; 19 Flores, Salmerón, Glenn, Lang, Chang, Bastani (bb0130) 2019; 64 Chao, Preciado, Slezak, Xu (bb0060) 2015; 56 de Sanjosé, Serrano, Tous (bb0095) 2018; 2 Fiks, Grundmeier, Mayne (bb0125) 2013; 131 Krawczyk, Perez, Lau (bb0265) 2012; 31 Shay, Street, Baldwin (bb0395) 2016; 99 (bb0430) 2011 Gilkey, Calo, Moss, Shah, Marciniak, Brewer (bb0170) 2016; 34 Kumar, Boies, Sawyer, Kennedy, Williams, Rhee (bb0270) 2019; 58 Bednarczyk, Whitehead, Stephenson (bb0015) 2017; 3 Macdonald (10.1016/j.ypmed.2021.106554_bb0280) 2016; 3 Curtis (10.1016/j.ypmed.2021.106554_bb0080) 2014; 63 Elam-Evans (10.1016/j.ypmed.2021.106554_bb0115) 2020; 69 Bednarczyk (10.1016/j.ypmed.2021.106554_bb0010) 2011; 29 Hansen (10.1016/j.ypmed.2021.106554_bb0195) 2017; 87 Fu (10.1016/j.ypmed.2021.106554_bb0135) 2017; 35 Klosky (10.1016/j.ypmed.2021.106554_bb0240) 2013; 6 de Martel (10.1016/j.ypmed.2021.106554_bb0090) 2017; 141 de Sanjosé (10.1016/j.ypmed.2021.106554_bb0095) 2018; 2 Gottlieb (10.1016/j.ypmed.2021.106554_bb0185) 2009; 45 (10.1016/j.ypmed.2021.106554_bb0455) 2016 Cates (10.1016/j.ypmed.2021.106554_bb0055) 2010; 47 (10.1016/j.ypmed.2021.106554_bb0465) 2018 Ruffin (10.1016/j.ypmed.2021.106554_bb0375) 2015; 28 Berenson (10.1016/j.ypmed.2021.106554_bb0020) 2017; 13 Marchand (10.1016/j.ypmed.2021.106554_bb0285) 2012; 37 Guerry (10.1016/j.ypmed.2021.106554_bb0190) 2011; 29 (10.1016/j.ypmed.2021.106554_bb0445) 2014 (10.1016/j.ypmed.2021.106554_bb0435) 2012 Fenton (10.1016/j.ypmed.2021.106554_bb0120) 2018; 14 (10.1016/j.ypmed.2021.106554_bb0425) 2010 Flores (10.1016/j.ypmed.2021.106554_bb0130) 2019; 64 Donahue (10.1016/j.ypmed.2021.106554_bb0110) 2015; 2 Gerend (10.1016/j.ypmed.2021.106554_bb0155) 2016; 92 Brewer (10.1016/j.ypmed.2021.106554_bb0035) 2017; 18 Gerend (10.1016/j.ypmed.2021.106554_bb0150) 2013; 53 Gargano (10.1016/j.ypmed.2021.106554_bb0140) 2013; 9 Brewer (10.1016/j.ypmed.2021.106554_bb0030) 2011; 38 Kempe (10.1016/j.ypmed.2021.106554_bb0225) 2018; 18 Buechel (10.1016/j.ypmed.2021.106554_bb0040) 2018; 67 Bednarczyk (10.1016/j.ypmed.2021.106554_bb0015) 2017; 3 Saraiya (10.1016/j.ypmed.2021.106554_bb0380) 2015; 107 (10.1016/j.ypmed.2021.106554_bb0420) 2009 Gerend (10.1016/j.ypmed.2021.106554_bb0145) 2009; 45 Rossi (10.1016/j.ypmed.2021.106554_bb0370) 1987; Vol 4 Immunization and Infectious Diseases Objectives (10.1016/j.ypmed.2021.106554_bb0220) Kramer (10.1016/j.ypmed.2021.106554_bb0260) 2012; 16 Casey (10.1016/j.ypmed.2021.106554_bb0045) 2013; 34 Sturm (10.1016/j.ypmed.2021.106554_bb0405) 2017; 61 Wilson (10.1016/j.ypmed.2021.106554_bb0490) 2016; 16 Kharbanda (10.1016/j.ypmed.2021.106554_bb0235) 2011; 29 Rosen (10.1016/j.ypmed.2021.106554_bb0360) 2016; 32 Suryadevara (10.1016/j.ypmed.2021.106554_bb0410) 2016; 12 Reiter (10.1016/j.ypmed.2021.106554_bb0335) 2009; 69 Fiks (10.1016/j.ypmed.2021.106554_bb0125) 2013; 131 Senkomago (10.1016/j.ypmed.2021.106554_bb0390) 2019; 68 Rosenthal (10.1016/j.ypmed.2021.106554_bb0365) 2011; 29 McRee (10.1016/j.ypmed.2021.106554_bb0295) 2014; 32 Plummer (10.1016/j.ypmed.2021.106554_bb0325) 2016; 4 Dempsey (10.1016/j.ypmed.2021.106554_bb0105) 2018; 172 Perkins (10.1016/j.ypmed.2021.106554_bb0320) 2015; 33 Reiter (10.1016/j.ypmed.2021.106554_bb0350) 2014; 23 Vu (10.1016/j.ypmed.2021.106554_bb0480) 2019; 34 Daley (10.1016/j.ypmed.2021.106554_bb0085) 2010; 19 The National Immunization Survey-Teen (10.1016/j.ypmed.2021.106554_bb0475) 2021 Rahman (10.1016/j.ypmed.2021.106554_bb0330) 2015; 54 Stokley (10.1016/j.ypmed.2021.106554_bb0400) 2014; 63 Reiter (10.1016/j.ypmed.2021.106554_bb0340) 2013; 31 Meites (10.1016/j.ypmed.2021.106554_bb0300) 2019; 68 Chao (10.1016/j.ypmed.2021.106554_bb0060) 2015; 56 Newman (10.1016/j.ypmed.2021.106554_bb0310) 2018; 8 (10.1016/j.ypmed.2021.106554_bb0430) 2011 (10.1016/j.ypmed.2021.106554_bb0440) 2013 (10.1016/j.ypmed.2021.106554_bb0470) 2019 Cherven (10.1016/j.ypmed.2021.106554_bb0065) 2019; 125 (10.1016/j.ypmed.2021.106554_bb0450) 2015 (10.1016/j.ypmed.2021.106554_bb0460) 2017 Klosky (10.1016/j.ypmed.2021.106554_bb0245) 2015; 10 Cheung (10.1016/j.ypmed.2021.106554_bb0070) 2016; 45 Gerend (10.1016/j.ypmed.2021.106554_bb0160) 2016; 43 Szilagyi (10.1016/j.ypmed.2021.106554_bb0415) 2013; 13 LaMontagne (10.1016/j.ypmed.2021.106554_bb0275) 2017; 138 Nickel (10.1016/j.ypmed.2021.106554_bb0315) 2017; 8 Hoffman (10.1016/j.ypmed.2021.106554_bb0200) 2012; 25 Kumar (10.1016/j.ypmed.2021.106554_bb0270) 2019; 58 Reiter (10.1016/j.ypmed.2021.106554_bb0345) 2013; 103 Gorbach (10.1016/j.ypmed.2021.106554_bb0180) 2017; 44 Markowitz (10.1016/j.ypmed.2021.106554_bb0290) 2018; 18 Gilkey (10.1016/j.ypmed.2021.106554_bb0170) 2016; 34 Kempe (10.1016/j.ypmed.2021.106554_bb0230) 2019; 144 Shay (10.1016/j.ypmed.2021.106554_bb0395) 2016; 99 Klosky (10.1016/j.ypmed.2021.106554_bb0250) 2015; 62 Colón-López (10.1016/j.ypmed.2021.106554_bb0075) 2016; 27 Gerend (10.1016/j.ypmed.2021.106554_bb0165) 2019; 64 Savas (10.1016/j.ypmed.2021.106554_bb0385) 2012; 43 Gold (10.1016/j.ypmed.2021.106554_bb0175) 2013; 52 de Sanjose (10.1016/j.ypmed.2021.106554_bb0100) 2019; 39 Klosky (10.1016/j.ypmed.2021.106554_bb0255) 2017; 35 Williams (10.1016/j.ypmed.2021.106554_bb0485) 2013; 31 Bar-Shain (10.1016/j.ypmed.2021.106554_bb0005) 2015; 56 Bhatta (10.1016/j.ypmed.2021.106554_bb0025) 2015; 31 Krawczyk (10.1016/j.ypmed.2021.106554_bb0265) 2012; 31 National HPV Roundtable (10.1016/j.ypmed.2021.106554_bb0305) 2021 Caskey (10.1016/j.ypmed.2021.106554_bb0050) 2009; 45 Rosen (10.1016/j.ypmed.2021.106554_bb0355) 2015; 85 |
| References_xml | – volume: 52 start-page: 427 year: 2013 end-page: 432 ident: bb0175 article-title: Factors predicting completion of the human papillomavirus vaccine series publication-title: J. Adolesc. Health – volume: 54 start-page: 1328 year: 2015 end-page: 1333 ident: bb0330 article-title: Correlates of human papillomavirus vaccine completion among adolescent girl initiators publication-title: Clin. Pediatr. (Phila) – year: 2011 ident: bb0430 publication-title: The 2010 National Immunization Survey-Teen – year: 2010 ident: bb0425 publication-title: The 2009 National Immunization Survey-Teen – volume: 69 start-page: 475 year: 2009 end-page: 480 ident: bb0335 article-title: Parents’ health beliefs and HPV vaccination of their adolescent daughters publication-title: Soc. Sci. Med. – volume: 37 start-page: 1136 year: 2012 end-page: 1144 ident: bb0285 article-title: Low HPV vaccine coverage among female community college students publication-title: J. Community Health – year: 2020 ident: bb0220 article-title: Healthy People – volume: 107 year: 2015 ident: bb0380 article-title: US assessment of HPV types in cancers: implications for current and 9-valent HPV vaccines publication-title: J. Natl. Cancer Inst. – volume: 3 year: 2016 ident: bb0280 article-title: Expertise in everyday nurse-patient conversations: the importance of small talk publication-title: Glob Qual Nurs Res. – volume: 18 start-page: S3 year: 2018 end-page: S10 ident: bb0290 article-title: Ten years of human papillomavirus vaccination in the United States publication-title: Acad. Pediatr. – volume: 4 start-page: e609 year: 2016 end-page: e616 ident: bb0325 article-title: Global burden of cancers attributable to infections in 2012: a synthetic analysis publication-title: Lancet Glob. Health – volume: 29 start-page: 2235 year: 2011 end-page: 2241 ident: bb0190 article-title: Human papillomavirus vaccine initiation among adolescent girls in high-risk communities☆ publication-title: Vaccine. – volume: 44 start-page: 436 year: 2017 end-page: 441 ident: bb0180 article-title: Human Papillomavirus Vaccination Among Young Men Who Have Sex With Men and Transgender Women in 2 US Cities, 2012–2014 publication-title: Sex. Transm. Dis. – volume: 99 start-page: 1452 year: 2016 end-page: 1460 ident: bb0395 article-title: Characterizing safety-net providers’ HPV vaccine recommendations to undecided parents: a pilot study publication-title: Patient Educ. Couns. – volume: 9 start-page: 2627 year: 2013 end-page: 2633 ident: bb0140 article-title: Impact of a physician recommendation and parental immunization attitudes on receipt or intention to receive adolescent vaccines publication-title: Vaccines – volume: 16 start-page: 41 year: 2016 ident: bb0490 article-title: Factors related to HPV vaccine uptake and 3-dose completion among women in a low vaccination region of the USA: an observational study publication-title: BMC Womens Health – volume: 2 year: 2018 ident: bb0095 article-title: Burden of Human Papillomavirus (HPV)-Related Cancers Attributable to HPVs 6/11/16/18/31/33/45/52 and 58 publication-title: JNCI Cancer Spectr. – year: 2016 ident: bb0455 publication-title: The 2015 National Immunization Survey-Teen – volume: 45 start-page: 453 year: 2009 end-page: 462 ident: bb0050 article-title: Knowledge and early adoption of the HPV vaccine among girls and Young women: results of a National Survey publication-title: J. Adolesc. Health – volume: 10 start-page: 449 year: 2015 end-page: 456 ident: bb0245 article-title: Prevalence and predictors of human papillomavirus (HPV) vaccination among young women surviving childhood cancer publication-title: J. Cancer Surviv. – volume: 2 start-page: 892 year: 2015 end-page: 898 ident: bb0110 article-title: Human papillomavirus vaccine initiation among 9–13-year-olds in the United States publication-title: Prev. Med. Rep. – volume: 38 start-page: 197 year: 2011 end-page: 204 ident: bb0030 article-title: Longitudinal predictors of human papillomavirus vaccine initiation among adolescent girls in a high-risk geographic area publication-title: Sex. Transm. Dis. – volume: 27 start-page: 1411 year: 2016 end-page: 1426 ident: bb0075 article-title: Views on HPV and HPV vaccination: the experience at a Federal Qualified Clinic in Puerto Rico publication-title: J. Health Care Poor Underserved – volume: 64 start-page: 753 year: 2019 end-page: 762 ident: bb0165 article-title: Predictors of human papillomavirus vaccine completion among low-income Latina/o adolescents publication-title: J. Adolesc. Health – year: 2015 ident: bb0450 publication-title: The 2014 National Immunization Survey-Teen – volume: 31 start-page: 67 year: 2015 end-page: 75 ident: bb0025 article-title: Human papillomavirus vaccine awareness, uptake, and parental and health care provider communication among 11- to 18-year-old adolescents in a rural Appalachian Ohio County in the United States: HPV vaccine uptake among Appalachian adolescents publication-title: J. Rural. Health – volume: 53 start-page: 623 year: 2013 end-page: 629 ident: bb0150 article-title: Predictors of human papillomavirus vaccination among daughters of low-income Latina mothers: the role of acculturation publication-title: J. Adolesc. Health – year: 2019 ident: bb0470 publication-title: The 2018 National Immunization Survey-Teen – volume: 34 start-page: 71 year: 2013 end-page: 80 ident: bb0045 article-title: Predictors of initial uptake of human papillomavirus vaccine uptake among rural Appalachian Young women publication-title: J. Prim. Prev. – volume: 18 start-page: S101 year: 2018 end-page: S105 ident: bb0225 article-title: Can school-located vaccination have a major impact on human papillomavirus vaccination rates in the United States? publication-title: Acad. Pediatr. – volume: 56 start-page: S21 year: 2015 end-page: S26 ident: bb0005 article-title: Direct messaging to parents/guardians to improve adolescent immunizations publication-title: J. Adolesc. Health – volume: 39 start-page: 16 year: 2019 end-page: 22 ident: bb0100 article-title: Human papillomavirus vaccine disease impact beyond expectations publication-title: Curr. Opin. Virol. – volume: 63 start-page: 620 year: 2014 end-page: 624 ident: bb0400 article-title: Human papillomavirus vaccination coverage among adolescents, 2007-2013, and postlicensure vaccine safety monitoring, 2006-2014--United States publication-title: MMWR Morb. Mortal. Wkly Rep. – volume: 63 start-page: 61 year: 2014 end-page: 70 ident: bb0080 article-title: National human papillomavirus vaccination coverage among adolescents aged 13-17 years-National Immunization Survey--teen, United States, 2011 publication-title: MMWR Suppl. – volume: 69 start-page: 1109 year: 2020 end-page: 1116 ident: bb0115 article-title: National, Regional, State, and Selected Local Area Vaccination Coverage Among Adolescents Aged 13–17 Years — United States, 2019 publication-title: MMWR Morb. Mortal. Wkly Rep. – volume: 13 start-page: 2150 year: 2017 end-page: 2154 ident: bb0020 article-title: Relationship between maternal experiences and adolescent HPV vaccination publication-title: Human Vaccines Immunother. – volume: 172 year: 2018 ident: bb0105 article-title: Effect of a health care professional communication training intervention on adolescent human papillomavirus vaccination: a cluster randomized clinical trial publication-title: JAMA Pediatr. – volume: 144 year: 2019 ident: bb0230 article-title: HPV vaccine delivery practices by primary care physicians publication-title: Pediatrics – year: 2014 ident: bb0445 publication-title: The 2013 National Immunization Survey-Teen – volume: 14 start-page: 2503 year: 2018 end-page: 2509 ident: bb0120 article-title: Indicated or elective? The association of providers’ words with HPV vaccine receipt publication-title: Hum Vaccin Immunother. – volume: 87 start-page: 705 year: 2017 end-page: 714 ident: bb0195 article-title: Acceptability of school-based health centers for human papillomavirus vaccination visits: a mixed-methods study publication-title: J. Sch. Health – volume: 35 start-page: 3582 year: 2017 end-page: 3590 ident: bb0255 article-title: Human papillomavirus vaccination rates in Young Cancer survivors publication-title: JCO. – volume: 28 start-page: 324 year: 2015 end-page: 333 ident: bb0375 article-title: Impact of an electronic health record (EHR) reminder on human papillomavirus (HPV) vaccine initiation and timely completion publication-title: J. Am. Board Fam. Med. – year: 2021 ident: bb0475 article-title: Centers for Disease Control and Prevention – volume: 12 start-page: 1491 year: 2016 end-page: 1497 ident: bb0410 article-title: Student HPV vaccine attitudes and vaccine completion by education level publication-title: Human Vaccines Immunother. – volume: 43 start-page: S490 year: 2012 end-page: S496 ident: bb0385 article-title: Human Papillomavirus Vaccine publication-title: Am. J. Prev. Med. – volume: 61 start-page: 246 year: 2017 end-page: 251 ident: bb0405 article-title: Pediatrician-parent conversations about human papillomavirus vaccination: an analysis of audio recordings publication-title: J. Adolesc. Health – volume: 68 start-page: 698 year: 2019 end-page: 702 ident: bb0300 article-title: Human papillomavirus vaccination for adults: updated recommendations of the advisory committee on immunization practices publication-title: MMWR Morb. Mortal. Wkly Rep. – volume: 35 start-page: 802 year: 2017 end-page: 807 ident: bb0135 article-title: Associations of trust and healthcare provider advice with HPV vaccine acceptance among African American parents publication-title: Vaccine. – year: 2020 ident: bb0210 article-title: HPV You Are Key 2018 | Vaccine Education | CDC – volume: 64 start-page: 323 year: 2019 end-page: 332 ident: bb0130 article-title: Clinician offering is a key factor associated with HPV vaccine uptake among Mexican mothers in the USA and Mexico: a cross-sectional study publication-title: Int J Public Health. – volume: 23 start-page: 742 year: 2014 end-page: 754 ident: bb0350 article-title: Provider-verified HPV vaccine coverage among a National Sample of Hispanic adolescent females publication-title: Cancer Epidemiol. Biomark. Prev. – volume: 31 start-page: 3121 year: 2013 end-page: 3125 ident: bb0340 article-title: Correlates of HPV vaccination among adolescent females from Appalachia and reasons why their parents do not intend to vaccinate publication-title: Vaccine. – volume: 67 start-page: 341 year: 2018 end-page: 346 ident: bb0040 article-title: Determinants of human papillomavirus vaccination among U.S. Navy Personnel publication-title: Nurs. Res. – volume: 16 start-page: 102 year: 2012 end-page: 110 ident: bb0260 article-title: Inter-state variation in human papilloma virus vaccine coverage among adolescent girls in the 50 US states, 2007 publication-title: Matern. Child Health J. – volume: 85 start-page: 73 year: 2015 end-page: 81 ident: bb0355 article-title: School Nurses’ knowledge, attitudes, perceptions of role as opinion leader, and professional practice regarding human papillomavirus vaccine for youth publication-title: J. Sch. Health – volume: 58 start-page: 17 year: 2019 end-page: 23 ident: bb0270 article-title: A brief provider training video improves comfort with recommending the human papillomavirus vaccine publication-title: Clin. Pediatr. (Phila) – volume: 34 start-page: 415 year: 2019 end-page: 434 ident: bb0480 article-title: Human papillomavirus vaccination among diverse college students in the state of Georgia: who receives recommendation, who initiates and what are the reasons? publication-title: Health Educ. Res. – year: 2013 ident: bb0440 publication-title: The 2012 National Immunization Survey-Teen – volume: 29 start-page: 890 year: 2011 end-page: 895 ident: bb0365 article-title: Predictors of HPV vaccine uptake among women aged 19–26: importance of a physician’s recommendation publication-title: Vaccine. – year: 2021 ident: bb0215 article-title: Human Papillomavirus Vaccine (HPV) – volume: 18 start-page: 149 year: 2017 end-page: 207 ident: bb0035 article-title: Increasing vaccination: putting psychological science into action publication-title: Psychol. Sci. Public Interest – volume: 34 start-page: 1187 year: 2016 end-page: 1192 ident: bb0170 article-title: Provider communication and HPV vaccination: the impact of recommendation quality publication-title: Vaccine. – year: 2021 ident: bb0305 publication-title: The official website of the National HPV Vaccination Roundtable. – volume: 45 start-page: 430 year: 2009 end-page: 437 ident: bb0185 article-title: Human papillomavirus vaccine initiation in an area with elevated rates of cervical Cancer publication-title: J. Adolesc. Health – volume: 8 start-page: 169 year: 2017 end-page: 176 ident: bb0315 article-title: Factors associated with the human papillomavirus (HPV) vaccination across three countries following vaccination introduction publication-title: Prev. Med. Rep. – volume: 125 start-page: 3810 year: 2019 end-page: 3817 ident: bb0065 article-title: Intent and subsequent initiation of human papillomavirus vaccine among young cancer survivors publication-title: Cancer. – volume: 19 start-page: 1885 year: 2010 end-page: 1891 ident: bb0085 article-title: Influences on human papillomavirus vaccination status among female college students publication-title: J. Women’s Health – volume: 25 start-page: 305 year: 2012 end-page: 307 ident: bb0200 article-title: Human papillomavirus vaccination in female pediatric cancer survivors publication-title: J. Pediatr. Adolesc. Gynecol. – volume: 141 start-page: 664 year: 2017 end-page: 670 ident: bb0090 article-title: Worldwide burden of cancer attributable to HPV by site, country and HPV type: worldwide burden of cancer attributable to HPV publication-title: Int. J. Cancer – year: 2021 ident: bb0205 article-title: HPV Champion Toolkit – volume: 33 start-page: 1223 year: 2015 end-page: 1229 ident: bb0320 article-title: Effectiveness of a provider-focused intervention to improve HPV vaccination rates in boys and girls publication-title: Vaccine. – volume: 29 start-page: 3138 year: 2011 end-page: 3143 ident: bb0010 article-title: Human papillomavirus vaccine uptake and barriers: association with perceived risk, actual risk and race/ethnicity among female students at a New York state university, 2010 publication-title: Vaccine. – volume: 8 year: 2018 ident: bb0310 article-title: Parents’ uptake of human papillomavirus vaccines for their children: a systematic review and meta-analysis of observational studies publication-title: BMJ Open – volume: 92 start-page: 104 year: 2016 end-page: 107 ident: bb0155 article-title: Predictors of provider recommendation for HPV vaccine among young adult men and women: findings from a cross-sectional survey: table 1 publication-title: Sex. Transm. Infect. – volume: 47 start-page: 305 year: 2010 end-page: 308 ident: bb0055 article-title: How parents hear about human papillomavirus vaccine: implications for uptake publication-title: J. Adolesc. Health – volume: 68 start-page: 724 year: 2019 end-page: 728 ident: bb0390 article-title: Human Papillomavirus–Attributable Cancers — United States, 2012–2016 publication-title: MMWR Morb. Mortal. Wkly Rep. – volume: 32 start-page: 138 year: 2016 end-page: 148 ident: bb0360 article-title: School Nurses’ professional practice in the HPV vaccine decision-making process publication-title: J. Sch. Nurs. – volume: 3 start-page: 121 year: 2017 end-page: 125 ident: bb0015 article-title: Moving beyond sex: assessing the impact of gender identity on human papillomavirus vaccine recommendations and uptake among a national sample of rural-residing LGBT young adults publication-title: Papillomavirus Res. – volume: 131 start-page: 1114 year: 2013 end-page: 1124 ident: bb0125 article-title: Effectiveness of decision support for families, clinicians, or both on HPV vaccine receipt publication-title: Pediatrics. – year: 2009 ident: bb0420 publication-title: The 2008 National Immunization Survey-Teen – year: 2012 ident: bb0435 publication-title: The 2011 National Immunization Survey-Teen – volume: Vol 4 start-page: 3 year: 1987 end-page: 20 ident: bb0370 article-title: The iron law of evaluation and other metallic rules publication-title: Research in Social Problems and Public Policy – year: 2017 ident: bb0460 publication-title: The 2016 National Immunization Survey-Teen. U.S – volume: 43 start-page: 185 year: 2016 end-page: 191 ident: bb0160 article-title: Predictors of human papillomavirus vaccination among young men who have sex with men publication-title: Sex. Transm. Dis. – volume: 31 start-page: 685 year: 2012 end-page: 693 ident: bb0265 article-title: Human papillomavirus vaccination intentions and uptake in college women publication-title: Health Psychol. – volume: 13 start-page: 204 year: 2013 end-page: 213 ident: bb0415 article-title: A randomized trial of the effect of centralized reminder/recall on immunizations and preventive care visits for adolescents publication-title: Acad. Pediatr. – volume: 45 start-page: 283 year: 2016 end-page: 292 ident: bb0070 article-title: How methodological features affect effect sizes in education publication-title: Educ. Res. – volume: 138 start-page: 7 year: 2017 end-page: 14 ident: bb0275 article-title: Progress in HPV vaccination in low- and lower-middle-income countries publication-title: Int. J. Gynecol. Obstet. – volume: 56 start-page: 85 year: 2015 end-page: 90 ident: bb0060 article-title: A randomized intervention of reminder letter for human papillomavirus vaccine series completion publication-title: J. Adolesc. Health – volume: 103 start-page: 1419 year: 2013 end-page: 1427 ident: bb0345 article-title: Longitudinal predictors of human papillomavirus vaccination among a National sample of adolescent males publication-title: Am. J. Public Health – volume: 29 start-page: 2537 year: 2011 end-page: 2541 ident: bb0235 article-title: Text message reminders to promote human papillomavirus vaccination publication-title: Vaccine. – year: 2018 ident: bb0465 publication-title: The 2017 National Immunization Survey-Teen – volume: 32 start-page: 4736 year: 2014 end-page: 4742 ident: bb0295 article-title: HPV vaccination among lesbian and bisexual women: findings from a national survey of young adults publication-title: Vaccine. – volume: 45 start-page: 528 year: 2009 end-page: 531 ident: bb0145 article-title: Parental response to human papillomavirus vaccine availability: uptake and intentions publication-title: J. Adolesc. Health – volume: 62 start-page: 1630 year: 2015 end-page: 1636 ident: bb0250 article-title: Medical and sociodemographic factors associated with human papillomavirus (HPV) vaccination adherence among female survivors of childhood cancer: HPV vaccination in cancer survivors publication-title: Pediatr. Blood Cancer – volume: 31 start-page: 2937 year: 2013 end-page: 2946 ident: bb0485 article-title: Factors associated with human papillomavirus vaccination among young adult women in the United States publication-title: Vaccine. – volume: 6 start-page: 1101 year: 2013 end-page: 1110 ident: bb0240 article-title: Risk factors for non-initiation of the human papillomavirus vaccine among adolescent survivors of childhood cancer publication-title: Cancer Prev. Res. – volume: 31 start-page: 2937 issue: 28 year: 2013 ident: 10.1016/j.ypmed.2021.106554_bb0485 article-title: Factors associated with human papillomavirus vaccination among young adult women in the United States publication-title: Vaccine. doi: 10.1016/j.vaccine.2013.04.041 – volume: 43 start-page: S490 issue: 6 year: 2012 ident: 10.1016/j.ypmed.2021.106554_bb0385 article-title: Human Papillomavirus Vaccine publication-title: Am. J. Prev. Med. doi: 10.1016/j.amepre.2012.09.003 – volume: 39 start-page: 16 year: 2019 ident: 10.1016/j.ypmed.2021.106554_bb0100 article-title: Human papillomavirus vaccine disease impact beyond expectations publication-title: Curr. Opin. Virol. doi: 10.1016/j.coviro.2019.06.006 – volume: 25 start-page: 305 issue: 5 year: 2012 ident: 10.1016/j.ypmed.2021.106554_bb0200 article-title: Human papillomavirus vaccination in female pediatric cancer survivors publication-title: J. Pediatr. Adolesc. Gynecol. doi: 10.1016/j.jpag.2012.05.004 – year: 2010 ident: 10.1016/j.ypmed.2021.106554_bb0425 – volume: 13 start-page: 204 issue: 3 year: 2013 ident: 10.1016/j.ypmed.2021.106554_bb0415 article-title: A randomized trial of the effect of centralized reminder/recall on immunizations and preventive care visits for adolescents publication-title: Acad. Pediatr. doi: 10.1016/j.acap.2013.01.002 – volume: 3 start-page: 121 year: 2017 ident: 10.1016/j.ypmed.2021.106554_bb0015 article-title: Moving beyond sex: assessing the impact of gender identity on human papillomavirus vaccine recommendations and uptake among a national sample of rural-residing LGBT young adults publication-title: Papillomavirus Res. doi: 10.1016/j.pvr.2017.04.002 – volume: 125 start-page: 3810 issue: 21 year: 2019 ident: 10.1016/j.ypmed.2021.106554_bb0065 article-title: Intent and subsequent initiation of human papillomavirus vaccine among young cancer survivors publication-title: Cancer. doi: 10.1002/cncr.32379 – volume: 45 start-page: 430 issue: 5 year: 2009 ident: 10.1016/j.ypmed.2021.106554_bb0185 article-title: Human papillomavirus vaccine initiation in an area with elevated rates of cervical Cancer publication-title: J. Adolesc. Health doi: 10.1016/j.jadohealth.2009.03.029 – volume: 16 start-page: 41 issue: 1 year: 2016 ident: 10.1016/j.ypmed.2021.106554_bb0490 article-title: Factors related to HPV vaccine uptake and 3-dose completion among women in a low vaccination region of the USA: an observational study publication-title: BMC Womens Health doi: 10.1186/s12905-016-0323-5 – volume: 103 start-page: 1419 issue: 8 year: 2013 ident: 10.1016/j.ypmed.2021.106554_bb0345 article-title: Longitudinal predictors of human papillomavirus vaccination among a National sample of adolescent males publication-title: Am. J. Public Health doi: 10.2105/AJPH.2012.301189 – volume: 44 start-page: 436 issue: 7 year: 2017 ident: 10.1016/j.ypmed.2021.106554_bb0180 article-title: Human Papillomavirus Vaccination Among Young Men Who Have Sex With Men and Transgender Women in 2 US Cities, 2012–2014 publication-title: Sex. Transm. Dis. doi: 10.1097/OLQ.0000000000000626 – year: 2017 ident: 10.1016/j.ypmed.2021.106554_bb0460 – volume: 68 start-page: 724 issue: 33 year: 2019 ident: 10.1016/j.ypmed.2021.106554_bb0390 article-title: Human Papillomavirus–Attributable Cancers — United States, 2012–2016 publication-title: MMWR Morb. Mortal. Wkly Rep. doi: 10.15585/mmwr.mm6833a3 – volume: 54 start-page: 1328 issue: 14 year: 2015 ident: 10.1016/j.ypmed.2021.106554_bb0330 article-title: Correlates of human papillomavirus vaccine completion among adolescent girl initiators publication-title: Clin. Pediatr. (Phila) doi: 10.1177/0009922815579687 – volume: 107 issue: 6 year: 2015 ident: 10.1016/j.ypmed.2021.106554_bb0380 article-title: US assessment of HPV types in cancers: implications for current and 9-valent HPV vaccines publication-title: J. Natl. Cancer Inst. doi: 10.1093/jnci/djv086 – year: 2021 ident: 10.1016/j.ypmed.2021.106554_bb0305 publication-title: The official website of the National HPV Vaccination Roundtable. – volume: 28 start-page: 324 issue: 3 year: 2015 ident: 10.1016/j.ypmed.2021.106554_bb0375 article-title: Impact of an electronic health record (EHR) reminder on human papillomavirus (HPV) vaccine initiation and timely completion publication-title: J. Am. Board Fam. Med. doi: 10.3122/jabfm.2015.03.140082 – year: 2012 ident: 10.1016/j.ypmed.2021.106554_bb0435 – volume: 92 start-page: 104 issue: 2 year: 2016 ident: 10.1016/j.ypmed.2021.106554_bb0155 article-title: Predictors of provider recommendation for HPV vaccine among young adult men and women: findings from a cross-sectional survey: table 1 publication-title: Sex. Transm. Infect. doi: 10.1136/sextrans-2015-052088 – volume: 34 start-page: 1187 issue: 9 year: 2016 ident: 10.1016/j.ypmed.2021.106554_bb0170 article-title: Provider communication and HPV vaccination: the impact of recommendation quality publication-title: Vaccine. doi: 10.1016/j.vaccine.2016.01.023 – volume: 27 start-page: 1411 issue: 3 year: 2016 ident: 10.1016/j.ypmed.2021.106554_bb0075 article-title: Views on HPV and HPV vaccination: the experience at a Federal Qualified Clinic in Puerto Rico publication-title: J. Health Care Poor Underserved doi: 10.1353/hpu.2016.0126 – volume: 64 start-page: 753 issue: 6 year: 2019 ident: 10.1016/j.ypmed.2021.106554_bb0165 article-title: Predictors of human papillomavirus vaccine completion among low-income Latina/o adolescents publication-title: J. Adolesc. Health doi: 10.1016/j.jadohealth.2018.12.001 – volume: 33 start-page: 1223 issue: 9 year: 2015 ident: 10.1016/j.ypmed.2021.106554_bb0320 article-title: Effectiveness of a provider-focused intervention to improve HPV vaccination rates in boys and girls publication-title: Vaccine. doi: 10.1016/j.vaccine.2014.11.021 – year: 2021 ident: 10.1016/j.ypmed.2021.106554_bb0475 – volume: 31 start-page: 3121 issue: 31 year: 2013 ident: 10.1016/j.ypmed.2021.106554_bb0340 article-title: Correlates of HPV vaccination among adolescent females from Appalachia and reasons why their parents do not intend to vaccinate publication-title: Vaccine. doi: 10.1016/j.vaccine.2013.04.068 – volume: 35 start-page: 802 issue: 5 year: 2017 ident: 10.1016/j.ypmed.2021.106554_bb0135 article-title: Associations of trust and healthcare provider advice with HPV vaccine acceptance among African American parents publication-title: Vaccine. doi: 10.1016/j.vaccine.2016.12.045 – volume: 29 start-page: 890 issue: 5 year: 2011 ident: 10.1016/j.ypmed.2021.106554_bb0365 article-title: Predictors of HPV vaccine uptake among women aged 19–26: importance of a physician’s recommendation publication-title: Vaccine. doi: 10.1016/j.vaccine.2009.12.063 – year: 2009 ident: 10.1016/j.ypmed.2021.106554_bb0420 – volume: 43 start-page: 185 issue: 3 year: 2016 ident: 10.1016/j.ypmed.2021.106554_bb0160 article-title: Predictors of human papillomavirus vaccination among young men who have sex with men publication-title: Sex. Transm. Dis. doi: 10.1097/OLQ.0000000000000408 – volume: 68 start-page: 698 issue: 32 year: 2019 ident: 10.1016/j.ypmed.2021.106554_bb0300 article-title: Human papillomavirus vaccination for adults: updated recommendations of the advisory committee on immunization practices publication-title: MMWR Morb. Mortal. Wkly Rep. doi: 10.15585/mmwr.mm6832a3 – volume: 45 start-page: 453 issue: 5 year: 2009 ident: 10.1016/j.ypmed.2021.106554_bb0050 article-title: Knowledge and early adoption of the HPV vaccine among girls and Young women: results of a National Survey publication-title: J. Adolesc. Health doi: 10.1016/j.jadohealth.2009.04.021 – volume: 38 start-page: 197 issue: 3 year: 2011 ident: 10.1016/j.ypmed.2021.106554_bb0030 article-title: Longitudinal predictors of human papillomavirus vaccine initiation among adolescent girls in a high-risk geographic area publication-title: Sex. Transm. Dis. doi: 10.1097/OLQ.0b013e3181f12dbf – volume: 63 start-page: 61 issue: 2 year: 2014 ident: 10.1016/j.ypmed.2021.106554_bb0080 article-title: National human papillomavirus vaccination coverage among adolescents aged 13-17 years-National Immunization Survey--teen, United States, 2011 publication-title: MMWR Suppl. – volume: 31 start-page: 67 issue: 1 year: 2015 ident: 10.1016/j.ypmed.2021.106554_bb0025 article-title: Human papillomavirus vaccine awareness, uptake, and parental and health care provider communication among 11- to 18-year-old adolescents in a rural Appalachian Ohio County in the United States: HPV vaccine uptake among Appalachian adolescents publication-title: J. Rural. Health doi: 10.1111/jrh.12079 – volume: 8 issue: 4 year: 2018 ident: 10.1016/j.ypmed.2021.106554_bb0310 article-title: Parents’ uptake of human papillomavirus vaccines for their children: a systematic review and meta-analysis of observational studies publication-title: BMJ Open doi: 10.1136/bmjopen-2017-019206 – volume: 56 start-page: S21 issue: 5, S year: 2015 ident: 10.1016/j.ypmed.2021.106554_bb0005 article-title: Direct messaging to parents/guardians to improve adolescent immunizations publication-title: J. Adolesc. Health doi: 10.1016/j.jadohealth.2014.11.023 – volume: 32 start-page: 4736 issue: 37 year: 2014 ident: 10.1016/j.ypmed.2021.106554_bb0295 article-title: HPV vaccination among lesbian and bisexual women: findings from a national survey of young adults publication-title: Vaccine. doi: 10.1016/j.vaccine.2014.07.001 – volume: 8 start-page: 169 year: 2017 ident: 10.1016/j.ypmed.2021.106554_bb0315 article-title: Factors associated with the human papillomavirus (HPV) vaccination across three countries following vaccination introduction publication-title: Prev. Med. Rep. doi: 10.1016/j.pmedr.2017.10.005 – volume: 10 start-page: 449 issue: 3 year: 2015 ident: 10.1016/j.ypmed.2021.106554_bb0245 article-title: Prevalence and predictors of human papillomavirus (HPV) vaccination among young women surviving childhood cancer publication-title: J. Cancer Surviv. doi: 10.1007/s11764-015-0495-2 – volume: 45 start-page: 283 issue: 5 year: 2016 ident: 10.1016/j.ypmed.2021.106554_bb0070 article-title: How methodological features affect effect sizes in education publication-title: Educ. Res. doi: 10.3102/0013189X16656615 – volume: 85 start-page: 73 issue: 2 year: 2015 ident: 10.1016/j.ypmed.2021.106554_bb0355 article-title: School Nurses’ knowledge, attitudes, perceptions of role as opinion leader, and professional practice regarding human papillomavirus vaccine for youth publication-title: J. Sch. Health doi: 10.1111/josh.12229 – volume: 18 start-page: 149 issue: 3 year: 2017 ident: 10.1016/j.ypmed.2021.106554_bb0035 article-title: Increasing vaccination: putting psychological science into action publication-title: Psychol. Sci. Public Interest doi: 10.1177/1529100618760521 – volume: 45 start-page: 528 issue: 5 year: 2009 ident: 10.1016/j.ypmed.2021.106554_bb0145 article-title: Parental response to human papillomavirus vaccine availability: uptake and intentions publication-title: J. Adolesc. Health doi: 10.1016/j.jadohealth.2009.02.006 – volume: 29 start-page: 2537 issue: 14 year: 2011 ident: 10.1016/j.ypmed.2021.106554_bb0235 article-title: Text message reminders to promote human papillomavirus vaccination publication-title: Vaccine. doi: 10.1016/j.vaccine.2011.01.065 – year: 2019 ident: 10.1016/j.ypmed.2021.106554_bb0470 – volume: 67 start-page: 341 issue: 4 year: 2018 ident: 10.1016/j.ypmed.2021.106554_bb0040 article-title: Determinants of human papillomavirus vaccination among U.S. Navy Personnel publication-title: Nurs. Res. doi: 10.1097/NNR.0000000000000282 – volume: 144 issue: 4 year: 2019 ident: 10.1016/j.ypmed.2021.106554_bb0230 article-title: HPV vaccine delivery practices by primary care physicians publication-title: Pediatrics doi: 10.1542/peds.2019-1475 – volume: 131 start-page: 1114 issue: 6 year: 2013 ident: 10.1016/j.ypmed.2021.106554_bb0125 article-title: Effectiveness of decision support for families, clinicians, or both on HPV vaccine receipt publication-title: Pediatrics. doi: 10.1542/peds.2012-3122 – year: 2016 ident: 10.1016/j.ypmed.2021.106554_bb0455 – volume: 47 start-page: 305 issue: 3 year: 2010 ident: 10.1016/j.ypmed.2021.106554_bb0055 article-title: How parents hear about human papillomavirus vaccine: implications for uptake publication-title: J. Adolesc. Health doi: 10.1016/j.jadohealth.2010.04.003 – volume: 141 start-page: 664 issue: 4 year: 2017 ident: 10.1016/j.ypmed.2021.106554_bb0090 article-title: Worldwide burden of cancer attributable to HPV by site, country and HPV type: worldwide burden of cancer attributable to HPV publication-title: Int. J. Cancer doi: 10.1002/ijc.30716 – volume: 34 start-page: 415 issue: 4 year: 2019 ident: 10.1016/j.ypmed.2021.106554_bb0480 article-title: Human papillomavirus vaccination among diverse college students in the state of Georgia: who receives recommendation, who initiates and what are the reasons? publication-title: Health Educ. Res. doi: 10.1093/her/cyz014 – volume: 9 start-page: 2627 issue: 12 year: 2013 ident: 10.1016/j.ypmed.2021.106554_bb0140 article-title: Impact of a physician recommendation and parental immunization attitudes on receipt or intention to receive adolescent vaccines publication-title: Vaccines doi: 10.4161/hv.25823 – volume: 69 start-page: 1109 issue: 33 year: 2020 ident: 10.1016/j.ypmed.2021.106554_bb0115 article-title: National, Regional, State, and Selected Local Area Vaccination Coverage Among Adolescents Aged 13–17 Years — United States, 2019 publication-title: MMWR Morb. Mortal. Wkly Rep. doi: 10.15585/mmwr.mm6933a1 – volume: 18 start-page: S101 issue: 2 year: 2018 ident: 10.1016/j.ypmed.2021.106554_bb0225 article-title: Can school-located vaccination have a major impact on human papillomavirus vaccination rates in the United States? publication-title: Acad. Pediatr. doi: 10.1016/j.acap.2017.08.010 – volume: 138 start-page: 7 year: 2017 ident: 10.1016/j.ypmed.2021.106554_bb0275 article-title: Progress in HPV vaccination in low- and lower-middle-income countries publication-title: Int. J. Gynecol. Obstet. doi: 10.1002/ijgo.12186 – volume: 2 start-page: 892 year: 2015 ident: 10.1016/j.ypmed.2021.106554_bb0110 article-title: Human papillomavirus vaccine initiation among 9–13-year-olds in the United States publication-title: Prev. Med. Rep. doi: 10.1016/j.pmedr.2015.10.003 – year: 2011 ident: 10.1016/j.ypmed.2021.106554_bb0430 – volume: 52 start-page: 427 issue: 4 year: 2013 ident: 10.1016/j.ypmed.2021.106554_bb0175 article-title: Factors predicting completion of the human papillomavirus vaccine series publication-title: J. Adolesc. Health doi: 10.1016/j.jadohealth.2012.09.009 – volume: 53 start-page: 623 issue: 5 year: 2013 ident: 10.1016/j.ypmed.2021.106554_bb0150 article-title: Predictors of human papillomavirus vaccination among daughters of low-income Latina mothers: the role of acculturation publication-title: J. Adolesc. Health doi: 10.1016/j.jadohealth.2013.06.006 – volume: 32 start-page: 138 issue: 2 year: 2016 ident: 10.1016/j.ypmed.2021.106554_bb0360 article-title: School Nurses’ professional practice in the HPV vaccine decision-making process publication-title: J. Sch. Nurs. doi: 10.1177/1059840515583312 – volume: 31 start-page: 685 issue: 5 year: 2012 ident: 10.1016/j.ypmed.2021.106554_bb0265 article-title: Human papillomavirus vaccination intentions and uptake in college women publication-title: Health Psychol. doi: 10.1037/a0027012 – volume: 69 start-page: 475 issue: 3 year: 2009 ident: 10.1016/j.ypmed.2021.106554_bb0335 article-title: Parents’ health beliefs and HPV vaccination of their adolescent daughters publication-title: Soc. Sci. Med. doi: 10.1016/j.socscimed.2009.05.024 – year: 2018 ident: 10.1016/j.ypmed.2021.106554_bb0465 – ident: 10.1016/j.ypmed.2021.106554_bb0220 – volume: 18 start-page: S3 issue: 2S year: 2018 ident: 10.1016/j.ypmed.2021.106554_bb0290 article-title: Ten years of human papillomavirus vaccination in the United States publication-title: Acad. Pediatr. doi: 10.1016/j.acap.2017.09.014 – year: 2015 ident: 10.1016/j.ypmed.2021.106554_bb0450 – volume: 35 start-page: 3582 issue: 31 year: 2017 ident: 10.1016/j.ypmed.2021.106554_bb0255 article-title: Human papillomavirus vaccination rates in Young Cancer survivors publication-title: JCO. doi: 10.1200/JCO.2017.74.1843 – volume: 16 start-page: 102 issue: S1 year: 2012 ident: 10.1016/j.ypmed.2021.106554_bb0260 article-title: Inter-state variation in human papilloma virus vaccine coverage among adolescent girls in the 50 US states, 2007 publication-title: Matern. Child Health J. doi: 10.1007/s10995-012-0999-6 – volume: 37 start-page: 1136 issue: 6 year: 2012 ident: 10.1016/j.ypmed.2021.106554_bb0285 article-title: Low HPV vaccine coverage among female community college students publication-title: J. Community Health doi: 10.1007/s10900-012-9572-x – volume: 4 start-page: e609 issue: 9 year: 2016 ident: 10.1016/j.ypmed.2021.106554_bb0325 article-title: Global burden of cancers attributable to infections in 2012: a synthetic analysis publication-title: Lancet Glob. Health doi: 10.1016/S2214-109X(16)30143-7 – volume: 23 start-page: 742 issue: 5 year: 2014 ident: 10.1016/j.ypmed.2021.106554_bb0350 article-title: Provider-verified HPV vaccine coverage among a National Sample of Hispanic adolescent females publication-title: Cancer Epidemiol. Biomark. Prev. doi: 10.1158/1055-9965.EPI-13-0979 – volume: 2 issue: 4 year: 2018 ident: 10.1016/j.ypmed.2021.106554_bb0095 article-title: Burden of Human Papillomavirus (HPV)-Related Cancers Attributable to HPVs 6/11/16/18/31/33/45/52 and 58 publication-title: JNCI Cancer Spectr. doi: 10.1093/jncics/pky045 – volume: 34 start-page: 71 issue: 1–2 year: 2013 ident: 10.1016/j.ypmed.2021.106554_bb0045 article-title: Predictors of initial uptake of human papillomavirus vaccine uptake among rural Appalachian Young women publication-title: J. Prim. Prev. doi: 10.1007/s10935-013-0295-2 – volume: 172 issue: 5 year: 2018 ident: 10.1016/j.ypmed.2021.106554_bb0105 article-title: Effect of a health care professional communication training intervention on adolescent human papillomavirus vaccination: a cluster randomized clinical trial publication-title: JAMA Pediatr. doi: 10.1001/jamapediatrics.2018.0016 – volume: 29 start-page: 3138 issue: 17 year: 2011 ident: 10.1016/j.ypmed.2021.106554_bb0010 article-title: Human papillomavirus vaccine uptake and barriers: association with perceived risk, actual risk and race/ethnicity among female students at a New York state university, 2010 publication-title: Vaccine. doi: 10.1016/j.vaccine.2011.02.045 – year: 2014 ident: 10.1016/j.ypmed.2021.106554_bb0445 – volume: 56 start-page: 85 issue: 1 year: 2015 ident: 10.1016/j.ypmed.2021.106554_bb0060 article-title: A randomized intervention of reminder letter for human papillomavirus vaccine series completion publication-title: J. Adolesc. Health doi: 10.1016/j.jadohealth.2014.08.014 – volume: 12 start-page: 1491 issue: 6 year: 2016 ident: 10.1016/j.ypmed.2021.106554_bb0410 article-title: Student HPV vaccine attitudes and vaccine completion by education level publication-title: Human Vaccines Immunother. doi: 10.1080/21645515.2015.1123359 – volume: 61 start-page: 246 issue: 2 year: 2017 ident: 10.1016/j.ypmed.2021.106554_bb0405 article-title: Pediatrician-parent conversations about human papillomavirus vaccination: an analysis of audio recordings publication-title: J. Adolesc. Health doi: 10.1016/j.jadohealth.2017.02.006 – volume: 64 start-page: 323 issue: 3 year: 2019 ident: 10.1016/j.ypmed.2021.106554_bb0130 article-title: Clinician offering is a key factor associated with HPV vaccine uptake among Mexican mothers in the USA and Mexico: a cross-sectional study publication-title: Int J Public Health. doi: 10.1007/s00038-018-1176-5 – volume: 3 year: 2016 ident: 10.1016/j.ypmed.2021.106554_bb0280 article-title: Expertise in everyday nurse-patient conversations: the importance of small talk publication-title: Glob Qual Nurs Res. – volume: 63 start-page: 620 issue: 29 year: 2014 ident: 10.1016/j.ypmed.2021.106554_bb0400 article-title: Human papillomavirus vaccination coverage among adolescents, 2007-2013, and postlicensure vaccine safety monitoring, 2006-2014--United States publication-title: MMWR Morb. Mortal. Wkly Rep. – volume: 19 start-page: 1885 issue: 10 year: 2010 ident: 10.1016/j.ypmed.2021.106554_bb0085 article-title: Influences on human papillomavirus vaccination status among female college students publication-title: J. Women’s Health doi: 10.1089/jwh.2009.1861 – volume: 87 start-page: 705 issue: 9 year: 2017 ident: 10.1016/j.ypmed.2021.106554_bb0195 article-title: Acceptability of school-based health centers for human papillomavirus vaccination visits: a mixed-methods study publication-title: J. Sch. Health doi: 10.1111/josh.12540 – volume: 58 start-page: 17 issue: 1 year: 2019 ident: 10.1016/j.ypmed.2021.106554_bb0270 article-title: A brief provider training video improves comfort with recommending the human papillomavirus vaccine publication-title: Clin. Pediatr. (Phila) doi: 10.1177/0009922818805217 – year: 2013 ident: 10.1016/j.ypmed.2021.106554_bb0440 – volume: 62 start-page: 1630 issue: 9 year: 2015 ident: 10.1016/j.ypmed.2021.106554_bb0250 article-title: Medical and sociodemographic factors associated with human papillomavirus (HPV) vaccination adherence among female survivors of childhood cancer: HPV vaccination in cancer survivors publication-title: Pediatr. Blood Cancer doi: 10.1002/pbc.25539 – volume: Vol 4 start-page: 3 year: 1987 ident: 10.1016/j.ypmed.2021.106554_bb0370 article-title: The iron law of evaluation and other metallic rules – volume: 99 start-page: 1452 issue: 9 year: 2016 ident: 10.1016/j.ypmed.2021.106554_bb0395 article-title: Characterizing safety-net providers’ HPV vaccine recommendations to undecided parents: a pilot study publication-title: Patient Educ. Couns. doi: 10.1016/j.pec.2016.06.027 – volume: 14 start-page: 2503 issue: 10 year: 2018 ident: 10.1016/j.ypmed.2021.106554_bb0120 article-title: Indicated or elective? The association of providers’ words with HPV vaccine receipt publication-title: Hum Vaccin Immunother. doi: 10.1080/21645515.2018.1480237 – volume: 29 start-page: 2235 issue: 12 year: 2011 ident: 10.1016/j.ypmed.2021.106554_bb0190 article-title: Human papillomavirus vaccine initiation among adolescent girls in high-risk communities☆ publication-title: Vaccine. doi: 10.1016/j.vaccine.2011.01.052 – volume: 13 start-page: 2150 issue: 9 year: 2017 ident: 10.1016/j.ypmed.2021.106554_bb0020 article-title: Relationship between maternal experiences and adolescent HPV vaccination publication-title: Human Vaccines Immunother. doi: 10.1080/21645515.2017.1332551 – volume: 6 start-page: 1101 issue: 10 year: 2013 ident: 10.1016/j.ypmed.2021.106554_bb0240 article-title: Risk factors for non-initiation of the human papillomavirus vaccine among adolescent survivors of childhood cancer publication-title: Cancer Prev. Res. doi: 10.1158/1940-6207.CAPR-13-0127 |
| SSID | ssj0011604 |
| Score | 2.657694 |
| SecondaryResourceType | review_article |
| Snippet | Provider communication can be critically important to families as they consider HPV vaccination. We sought to characterize the association of provider... AbstractProvider communication can be critically important to families as they consider HPV vaccination. We sought to characterize the association of provider... |
| SourceID | proquest pubmed crossref elsevier |
| SourceType | Aggregation Database Index Database Enrichment Source Publisher |
| StartPage | 106554 |
| SubjectTerms | Adolescent Communication Female Health Knowledge, Attitudes, Practice Health Personnel HPV vaccines Humans Internal Medicine Male Meta-analysis Papillomavirus Infections - prevention & control Papillomavirus Vaccines Parents Provider communication Systematic review Vaccination |
| Title | Provider communication and HPV vaccine uptake: A meta-analysis and systematic review |
| URI | https://www.clinicalkey.com/#!/content/1-s2.0-S0091743521001389 https://www.clinicalkey.es/playcontent/1-s2.0-S0091743521001389 https://dx.doi.org/10.1016/j.ypmed.2021.106554 https://www.ncbi.nlm.nih.gov/pubmed/33857561 https://www.proquest.com/docview/2514593161 |
| Volume | 148 |
| WOSCitedRecordID | wos000663549000012&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D |
| hasFullText | 1 |
| inHoldings | 1 |
| isFullTextHit | |
| isPrint | |
| journalDatabaseRights | – providerCode: PRVESC databaseName: Elsevier SD Freedom Collection Journals 2021 customDbUrl: eissn: 1096-0260 dateEnd: 99991231 omitProxy: false ssIdentifier: ssj0011604 issn: 0091-7435 databaseCode: AIEXJ dateStart: 20141101 isFulltext: true titleUrlDefault: https://www.sciencedirect.com providerName: Elsevier |
| link | http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV3db9MwELe6DSEkhGAwKB-TkXgrqfLhxAlv7VQ00BiViFDfLDtxtI2SVk3abfz1nGMnbVdW2AMvVpXaTuL75Xz23f2M0DvFbxIJKS0JawUL7H_bilIqLO4QyUXmpZ5OFD6hp6fhaBQNW61fdS7MYkzzPLy6iqb_VdRwDYStUmfvIO6mU7gAv0HoUILYofwnwQ9Nbp2KFl_mflROguPh986CJ8qX3plPS_7DJKb_lCW3eE1PUm2l3yB4vlw1Ymvap4XccM1_PdPpW52TyUqSWV_xlGj_xpE6qOc87_S7javnbJJqXdUfXyszeND81Z_JSw2pKgI37q7uUbhOE8_a6N3IscBW8df0rqbYNJoTlqa-ppPeUOp6f-Giez2Fl-qq_rvL2usU2jemtibgsI5lu2BVJ0x1wnQnO2jPpX4EGnGv92kw-tz4oJzA1hze5tlrzqoqOnDjWW6za25bt1T2S_wYPTILD9zTgHmCWjLfR_e_GPnto4d6AxfrvLSnKK5xhNdwhAEdGHCEDY6wxtEH3MNrKKrqLVGENYqeofjjID46tswRHFZCgqBUpU_BpBZBZgsqQFsnsGCGaSCQoUcJEakkGZeSOAlNvczmJIxIEhJBFGlU5B2g3XySyxcIJyLljqBulvGUgM0dZoGnjjtPMydLeei3kVuPH0sMPb06JWXMtsiujd43jaaanWV7dVILhtWJxzBVMgDa9mb0T81kYb76gjmscJnNvimsKKi4jo4AaKOgaWksWm2p_v2Wb2vcMND3yonHczmZFwxGn_iRBwu1NnquAdW8uuep83YD5-XdhuUVerD8aF-j3XI2l2_QvWRRnhezQ7RDR-Gh-Th-AyJD1Ms |
| linkProvider | Elsevier |
| openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Provider+communication+and+HPV+vaccine+uptake%3A+A+meta-analysis+and+systematic+review&rft.jtitle=Preventive+medicine&rft.au=Oh%2C+N.+Loren&rft.au=Biddell%2C+Caitlin+B.&rft.au=Rhodes%2C+Blythe+E.&rft.au=Brewer%2C+Noel+T.&rft.date=2021-07-01&rft.issn=0091-7435&rft.volume=148&rft.spage=106554&rft_id=info:doi/10.1016%2Fj.ypmed.2021.106554&rft.externalDBID=n%2Fa&rft.externalDocID=10_1016_j_ypmed_2021_106554 |
| thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0091-7435&client=summon |
| thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0091-7435&client=summon |
| thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0091-7435&client=summon |